Avicanna Inc
TSX:AVCN

Watchlist Manager
Avicanna Inc Logo
Avicanna Inc
TSX:AVCN
Watchlist
Price: 0.23 CAD 4.55%
Market Cap: 27.1m CAD

Avicanna Inc
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Avicanna Inc
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Avicanna Inc
TSX:AVCN
Free Cash Flow
-CA$1.8m
CAGR 3-Years
40%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Bausch Health Companies Inc
TSX:BHC
Free Cash Flow
$1.1B
CAGR 3-Years
N/A
CAGR 5-Years
11%
CAGR 10-Years
-6%
Canopy Growth Corp
TSX:WEED
Free Cash Flow
-CA$96.1m
CAGR 3-Years
45%
CAGR 5-Years
38%
CAGR 10-Years
-15%
Sundial Growers Inc
NASDAQ:SNDL
Free Cash Flow
CA$57.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Free Cash Flow
-$5.7m
CAGR 3-Years
62%
CAGR 5-Years
50%
CAGR 10-Years
-3%
K
Knight Therapeutics Inc
TSX:GUD
Free Cash Flow
CA$2.8m
CAGR 3-Years
-46%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Avicanna Inc
Glance View

Market Cap
27.1m CAD
Industry
Pharmaceuticals

Avicanna, Inc. is a medical cannabis company, which intends to engage in the business of discovery and development processes, intellectual property portfolio, strategic relationships, and cultivation infrastructure. The company is headquartered in Toronto, Ontario and currently employs 18 full-time employees. The company went IPO on 2019-07-18. The firm is engaged in cannabinoid research, development, and evidence-based products for the global consumer, as well as medical and pharmaceutical market segments. The firm's scientific platform commercializes over twenty products across four market segments: Medical Cannabis & Wellness Products, CBD Derma-Cosmetic Products, Pharmaceuticals and Cannabis Raw Materials, Seeds, and Bulk Formulations. Its Medical Cannabis & Wellness Products are an advanced line of pharmaceutical-grade cannabis products containing varying ratios of cannabidiol (CBD) and tetrahydrocannabinol (THC), marketed under the RHO Phyto brand. Its CBD Derma-Cosmetic Products are marketed under the Pura H&W or Pura Earth brands. Its cannabinoid-based drug candidates provide solutions for unmet medical needs in the areas of dermatology, chronic pain, and various neurological disorders.

AVCN Intrinsic Value
0.37 CAD
Undervaluation 38%
Intrinsic Value
Price

See Also

What is Avicanna Inc's Free Cash Flow?
Free Cash Flow
-1.8m CAD

Based on the financial report for Sep 30, 2025, Avicanna Inc's Free Cash Flow amounts to -1.8m CAD.

What is Avicanna Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
37%

Over the last year, the Free Cash Flow growth was 46%. The average annual Free Cash Flow growth rates for Avicanna Inc have been 40% over the past three years , 37% over the past five years .

Back to Top